US 10894804
Nucleotide hemi-sulfate salt for the treatment of hepatitis C virus
granted A61KA61K31/7076A61K31/708
Quick answer
US patent 10894804 (Nucleotide hemi-sulfate salt for the treatment of hepatitis C virus) held by Atea Pharmaceuticals, Inc. expires Mon Jan 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Atea Pharmaceuticals, Inc.
- Grant date
- Tue Jan 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 37
- CPC classes
- A61K, A61K31/7076, A61K31/708, A61K45/06, A61K9/20